U.S. Vaccine Initiative To Work With 7 Pharmaceutical Companies On 5 Novel Coronavirus Vaccine Candidates
Bloomberg: White House Works With Seven Drugmakers in ‘Warp Speed’ Push
“The White House is working with seven pharmaceutical companies as part of its ‘Warp Speed’ coronavirus vaccine program, including a bet on a rapid-but-unproven genetic technology. The companies include Johnson & Johnson, Merck & Co., Pfizer Inc., the Cambridge, Massachusetts-based biotech Moderna Inc., and the University of Oxford in collaboration with AstraZeneca Plc, as well as two other firms, according to two people familiar with the matter. President Donald Trump was briefed Tuesday on the latest details on the project, according to one of the people…” (Griffin/Jacobs, 6/3).
Additional coverage of Operation Warp Speed is available from New York Times and Reuters.
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.